Company-wide revenue
Reported revenue in 2021 ¥1.01T Reported revenue in 2025 ¥1.17T
- growth amount
- +¥160.6B
- growth annualized
- +3.7%
- growth total
- +15.9%
Japanese company profile · 2269
Meiji Holdings Co., Ltd.
In its FY2025 public filing, Meiji Holdings Co., Ltd. reports Food Products, Pharmaceuticals. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 明治ホールディングス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Meiji Holdings Co., Ltd.'s largest reported business by revenue in FY2025 was Food Products.
The business with the highest reported segment profit in FY2025 was Food Products.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Food Products | ¥942.88B ↗ | 80.3% | ¥68.75B ↗ |
| Pharmaceuticals | ¥232.24B ↗ | 19.8% | ¥30.46B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Food Products
- 食品
- Pharmaceuticals
- 医薬品
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Food Products
- 食品
- Pharmaceuticals
- 医薬品
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Food Products | ¥826.08B | ¥865.61B | ¥900.13B | ¥925.55B | ¥942.88B |
| Pharmaceuticals | ¥187.98B | ¥197.28B | ¥206.11B | ¥229.65B | ¥232.24B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Food Products
Reported revenue in 2021 ¥826.08B Reported revenue in 2025 ¥942.88B
- growth amount
- +¥116.8B
- growth annualized
- +3.4%
- growth total
- +14.1%
View original filing
Pharmaceuticals
Reported revenue in 2021 ¥187.98B Reported revenue in 2025 ¥232.24B
- growth amount
- +¥44.26B
- growth annualized
- +5.4%
- growth total
- +23.5%
View original filing
Pharmaceuticals
Reported profit margin in 2022 +11.0%
Reported profit margin in 2025 +13.1%
- growth margin points
- +2.1
View original filing
Food Products
Reported profit margin in 2022 +6.5%
Reported profit margin in 2025 +7.3%
- growth margin points
- +0.8
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YILP
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.